NCT00199719View on ClinicalTrials.gov

Study of the Pharmacokinetic Action of Amantadine and Ribavirin in Chronic Hepatitis C. CINAM

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

June 30, 2003

Study Completion Date

September 30, 2006

Conditions
Chronic Hepatitis C
Interventions
DRUG

Ribavirine

Trial Locations (2)

Unknown

Service d'Hépato-gastroentérologie, Angers

Service d'Hépatogastroentérologie, Limoges

All Listed Sponsors
collaborator

Hoffmann-La Roche

INDUSTRY

lead

University Hospital, Limoges

OTHER

NCT00199719 - Study of the Pharmacokinetic Action of Amantadine and Ribavirin in Chronic Hepatitis C. CINAM | Biotech Hunter | Biotech Hunter